A systematic review and meta-analysis of 10 randomized controlled trials provides moderate evidence that eradication therapy reduces the incidence of...
Read moreIn a phase 3 trial, treatment with BOT (0.5 mg or 1 mg twice daily) was equally effective, safe and...
Read moreTime-restricted eating, in the absence of other interventions, was not more effective in weight loss than conventional eating (3 structured...
Read moreThe anti-Siglec-8 antibody AK002 significantly reduced gastrointestinal eosinophils and clinical symptoms in a phase 2 trial.
Read moreAccording to a retrospective analysis of 878 patients, famotidine use in hospitalized patients with COVID-19 was associated with a lower...
Read moreRipretinib, a tyrosine kinase inhibitor with broad activity even in the presence of mutations, significantly improved median progression-free survival compared...
Read moreAnalysis of a cohort of approx. 800 EoE patients revealed that psychiatric comorbidities (mainly anxiety or depression) affect nearly one...
Read moreThe use of liraglutide (3 mg) plus lifestyle therapy led to a significantly greater reduction in the body mass index...
Read moreThis basic science report demonstrates that gastric microbes are specifically associated with gastric inflammation, atrophy and intestinal metaplasia 1 year...
Read moreTherapy with trastuzumab deruxtecan, a conjugate of an anti-HER2 antibody and a topoisomerase I inhibitor, resulted in improved objective response...
Read more© 2024 JNews - Premium WordPress news & magazine theme by Jegtheme.
Si ya esta registrado ingrese aquí
Si ya esta registrado ingrese aquí